Tesmorelin 5mg
Tesamorelin is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH), studied within laboratory environments for its interaction with endocrine signalling pathways and regulatory systems.
In research settings, Tesamorelin is investigated for its role in pathways associated with growth hormone secretion, hypothalamic–pituitary axis signalling, and broader neuroendocrine regulation. Ongoing studies explore its interaction with receptor-mediated mechanisms involved in hormone signalling and systemic regulatory processes.
This compound is supplied as a lyophilized powder, manufactured to meet high standards of purity, structural integrity, and batch consistency, supporting controlled and reproducible research applications.
For research purposes only. Not for human consumption.
Compound Specifications
| Purity | ≥98% (HPLC) |
| Molecular Formula | C₁₄₉H₂₄₆N₄₄O₄₂S |
| Molecular Weight | 3,357.9 g/mol |
| CAS Number | 86168-78-7 |
| Amino Acid Sequence | Trans-3-hexenoic acid-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu |
Protocols
Our research protocols is structured to ensure consistency, reproducibility, and compliance within your research standards.
Need guidance on protocol design or implementation? Our consultation services provide expert support tailored to your research objectives.